TOP NEWS: AstraZeneca receives approval by EU for biologic Saphnelo
(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved its biologic Saphnelo for the treatment of moderate to severe systemic lupus erythematosus, an autoimmune condition. Read More